Florence Gazeau Selected Research

ferric oxide (iron oxide)

11/2021	Two step promotion of a hot tumor immune environment by gold decorated iron oxide nanoflowers and light-triggered mild hyperthermia.
1/2020	Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma.
2/2019	Thermoresponsive Iron Oxide Nanocubes for an Effective Clinical Translation of Magnetic Hyperthermia and Heat-Mediated Chemotherapy.
5/2014	Heat-generating iron oxide nanocubes: subtle "destructurators" of the tumoral microenvironment.
12/2012	Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.
6/2012	Adipose tissue macrophages: MR tracking to monitor obesity-associated inflammation.
4/2012	Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment.
5/2009	Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver.
2/2008	Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles.
8/2007	Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florence Gazeau Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 04/2004
15	Hyperthermia 11/2021 - 03/2007
5	Fistula 12/2021 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2004
3	Inflammation (Inflammations) 01/2021 - 06/2012
2	Cutaneous Fistula 07/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 05/2014
1	Anastomotic Leak 11/2022
1	Crohn Disease (Crohn's Disease) 12/2021
1	Esophageal Stenosis (Esophageal Stricture) 09/2021
1	Pain (Aches) 07/2021
1	Intestinal Fistula 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Necrosis 01/2021
1	Rheumatoid Arthritis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 02/2019
1	Lung Injury 10/2018
1	Starvation 05/2017
1	Body Weight (Weight, Body) 06/2012
1	Obesity 06/2012
1	Atherosclerotic Plaque (Atheroma) 07/2010
1	Muscular Diseases (Myopathy) 12/2009
1	Hepatocellular Carcinoma (Hepatoma) 05/2009
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2008
1	Abdominal Aortic Aneurysm 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2005

Drug/Important Bio-Agent (IBA)

13	ferric oxide (iron oxide)IBA 11/2021 - 09/2006
7	Pharmaceutical PreparationsIBA 01/2021 - 05/2014
6	GoldIBA 11/2021 - 12/2018
5	temoporfinIBA 01/2021 - 05/2017
5	IronIBA 02/2019 - 05/2006
4	CollagenIBA 01/2021 - 05/2014
3	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 04/2015
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 11/2018
3	Citric Acid (Citrate)FDA LinkGeneric 11/2020 - 07/2010
3	Liposomes (Liposome)IBA 08/2012 - 04/2004
2	HydrogelsIBA 09/2021 - 01/2021
2	Poloxamer (Poloxamer 407)IBA 07/2021 - 10/2018
2	SuspensionsIBA 12/2019 - 07/2012
2	OvalbuminIBA 12/2008 - 09/2006
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2007 - 04/2004
1	SaltsIBA 01/2022
1	CytokinesIBA 11/2021
1	PolymersIBA 07/2021
1	LipidsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2020
1	Therapeutic UsesIBA 10/2018
1	Biological ProductsIBA 10/2018
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 06/2012
1	PKH67IBA 05/2009
1	1- acetyl- 1- methyl- 2- nitroso- 2- phenylhydrazineIBA 05/2009
1	AntigensIBA 12/2008
1	Biocompatible Materials (Biomaterials)IBA 05/2008
1	cobalt ferriteIBA 02/2008
1	RhodaminesIBA 03/2007
1	Hematoxylin (Haematoxylon)IBA 05/2006
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2006
1	ferric ferrocyanide (Prussian blue)FDA Link 05/2006
1	glucose receptorIBA 04/2004
1	Glucose (Dextrose)FDA LinkGeneric 04/2004
1	Contrast MediaIBA 04/2004

Therapy/Procedure

14	Therapeutics 12/2021 - 09/2006
4	Photothermal Therapy 11/2021 - 01/2017
3	Lasers (Laser) 01/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2017
2	Immunotherapy 11/2021 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 01/2021 - 05/2017
2	Cytoreduction Surgical Procedures 01/2021 - 01/2021
2	Intravenous Injections 07/2020 - 05/2006
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2008 - 08/2005
1	Surgical Instruments (Clip) 11/2022
1	Biological Therapy 12/2021
1	Stents 07/2021
1	Off-Label Use 07/2021
1	Aftercare (After-Treatment) 07/2021
1	Cecostomy 01/2021
1	Intraperitoneal Injections 01/2021
1	Hyperthermic Intraperitoneal Chemotherapy 01/2021
1	Precision Medicine 05/2017
1	Autologous Transplantation 12/2009
1	Cell Transplantation 05/2009